Innoviva, Inc. Common Stock
Symbol: INVA (NASDAQ)
18.21
▼ (-0.76%) -0.140
Company Description:
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Key Stats
- Today's Open: $18.31
- Today's High: $19.55
- Today's Low: $17.721
- Today's Volume: 402.12K
- Yesterday Close: $18.35
- Yesterday High: $18.79
- Yesterday Low: $17.22
- Yesterday Volume: 1.76M
- Last Min Volume: 1.36K
- Last Min High: $18.21
- Last Min Low: $18.205
- Last Min VWAP: $18.2073
Company Profile
- Name: Innoviva, Inc. Common Stock
- Website: https://www.inva.com
- Listed Date: 2004-10-05
- Location: BURLINGAME, CA
- Market Status: Active
- CIK Number: 0001080014
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.10B
- Round Lot: 100
- Outstanding Shares: 63.02M
- Asset Type: CS
RECENT FILINGS FOR INVA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-08 | SCHEDULE 13G/A | View |
| 2025-09-03 | SCHEDULE 13G/A | View |
| 2025-08-22 | 4 | View |
| 2025-08-22 | 4 | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13D/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G | View |
| 2025-08-05 | SCHEDULE 13G/A | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 8-K | View |
| 2025-05-07 | 10-Q | View |
| 2025-05-07 | 8-K | View |
| 2025-04-28 | SCHEDULE 13G/A | View |
Latest News on INVA